Clene Inc. Files 8-K on Financials and Operations

Ticker: CLNN · Form: 8-K · Filed: Oct 14, 2025 · CIK: 1822791

Clene Inc. 8-K Filing Summary
FieldDetail
CompanyClene Inc. (CLNN)
Form Type8-K
Filed DateOct 14, 2025
Risk Levelmedium
Pages3
Reading Time3 min
Key Dollar Amounts$0.0001, $230.00
Sentimentneutral

Sentiment: neutral

Topics: financial-reporting, operations, sec-filing

TL;DR

Clene Inc. dropped an 8-K detailing its financials and operations - check it out!

AI Summary

Clene Inc. filed an 8-K on October 14, 2025, reporting on its results of operations and financial condition. The filing also includes information related to Regulation FD disclosure and financial statements and exhibits. Clene Inc. is incorporated in Delaware and is part of the Pharmaceutical Preparations industry.

Why It Matters

This 8-K filing provides crucial updates on Clene Inc.'s financial health and operational performance, which are essential for investors to assess the company's current standing and future prospects.

Risk Assessment

Risk Level: medium — 8-K filings can contain significant financial and operational updates that may impact a company's stock price, requiring careful review by investors.

Key Numbers

  • 001-39834 — SEC File Number (Identifies the company's filing with the SEC.)
  • 85-2828339 — IRS Employer Identification No. (Tax identification number for the company.)

Key Players & Entities

  • Clene Inc. (company) — Registrant
  • October 14, 2025 (date) — Date of earliest event reported
  • Delaware (jurisdiction) — State of incorporation
  • 85-2828339 (identifier) — IRS Employer Identification No.
  • 6550 South Millrock Drive, Suite G50 (address) — Principal executive address
  • Salt Lake City, Utah 84121 (address) — Principal executive address

FAQ

What specific financial results are being reported in this 8-K?

The filing indicates it reports on 'Results of Operations and Financial Condition' but does not provide specific figures within the provided text.

What is the primary business of Clene Inc. according to the filing?

Clene Inc. is classified under 'PHARMACEUTICAL PREPARATIONS [2834]'.

When was the earliest event reported in this 8-K filing?

The earliest event reported is dated October 14, 2025.

What is the principal executive address of Clene Inc.?

The principal executive address is 6550 South Millrock Drive, Suite G50, Salt Lake City, Utah 84121.

What other items are covered in this 8-K filing besides financial condition?

The filing also covers 'Regulation FD Disclosure' and 'Financial Statements and Exhibits'.

Filing Stats: 835 words · 3 min read · ~3 pages · Grade level 12.1 · Accepted 2025-10-14 08:00:12

Key Financial Figures

  • $0.0001 — nge on which registered Common Stock, $0.0001 par value CLNN The Nasdaq Capital M
  • $230.00 — rtieth of one share of Common Stock for $230.00 per share CLNNW The Nasdaq Capital

Filing Documents

02 Results of Operations and Financial Condition

Item 2.02 Results of Operations and Financial Condition. On October 14, 2025, Clene Inc. ("the Company") released an updated corporate presentation (the "Corporate Presentation") on its website, invest.clene.com, containing the Company's preliminary unaudited (i) balance of cash and cash equivalents as of September 30, 2025 and (ii) gross proceeds raised from the Company's equity distribution agreement (the "ATM Agreement") subsequent to September 30, 2025 through October 14, 2025 (together, the "Financial Information"). The Corporate Presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The Financial Information is based on preliminary unaudited information available to the Company and has been prepared by and is the responsibility of management. The Company's financial closing procedures for the three and nine months ended September 30, 2025 are not yet complete and, as a result, actual results may vary from the preliminary unaudited results presented herein due to the completion of the Company's financial closing procedures audit procedures. The preliminary Financial Information has not been audited or reviewed by the Company's independent registered public accounting firm and should not be viewed as a substitute for the Company's full financial statements. It is possible that the Company or its independent registered public accounting firm may identify necessary adjustments to the preliminary unaudited Financial Information and those changes could be material. Accordingly, you should not place undue reliance on this preliminary unaudited data. The information furnished in this Item 2.02, including Exhibit 99.1, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act"), as amended, or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing made by the Company under the Exchange Act or the Securities Act o

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. The information set forth in Item 2.02 of this Current Report on Form 8-K is incorporated into this Item 7.01 by reference. The information furnished in this Item 7.02, including Exhibit 99.1, shall not be deemed to be "filed" for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing made by the Company under the Exchange Act or the Securities Act regardless of any general incorporation language in any such filings, except as shall be expressly set forth by specific reference in such a filing.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Exhibit Description 99.1 Corporate Presentation. 104 Cover Page Interactive Data File (formatted as Inline XBRL). 1

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. CLENE INC. Date: October 14, 2025 By: /s/ Robert Etherington Robert Etherington President and Chief Executive Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.